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Abstract
Background: Hypertension is a major contributor to the global non-communicable disease burden. Family history
is an important non-modifiable risk factor for hypertension. The present study aims to describe the influence of
family history (FH) on hypertension prevalence and associated metabolic risk factors in a large cohort of South Asian
adults, from a nationally representative sample from Sri Lanka.
Methods: A cross-sectional survey among 5,000 Sri Lankan adults, evaluating FH at the levels of parents, grandparents,
siblings and children. A binary logistic regression analysis was performed in all patients with ‘presence of hypertension’
as dichotomous dependent variable and using family history in parents, grandparents, siblings and children as binary
independent variables. The adjusted odds ratio controlling for confounders (age, gender, body mass index, diabetes,
hyperlipidemia and physical activity) are presented below.
Results: In all adults the prevalence of hypertension was significantly higher in patients with a FH (29.3 %, n = 572/1951)
than those without (24.4 %, n = 616/2530) (p < 0.001). Presence of a FH significantly increased the risk of hypertension
(OR:1.29; 95 % CI:1.13-1.47), obesity (OR:1.36; 95 % CI: 1.27–1.45), central obesity (OR:1.30; 95 % CI 1.22–1.40) and
metabolic syndrome (OR:1.19; 95 % CI: 1.08–1.30). In all adults presence of family history in parents (OR:1.28; 95 % CI:
1.12–1.48), grandparents (OR:1.34; 95 % CI: 1.20–1.50) and siblings (OR:1.27; 95 % CI: 1.21–1.33) all were associated with
significantly increased risk of developing hypertension.
Conclusions: Our results show that the prevalence of hypertension was significantly higher in those with a FH of
hypertension. FH of hypertension was also associated with the prevalence of obesity, central obesity and metabolic
syndrome. Individuals with a FH of hypertension form an easily identifiable group who may benefit from targeted
interventions.
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Background
Hypertension is a major contributor to the global non-
communicable disease burden, affecting nearly one bil-
lion people worldwide [1,2]. It has become an important
public health challenge in both developing and devel-
oped countries [3]. The rapid economic development,
industrialisation and change in lifestyle seen in South
Asia have led to an increasing prevalence of hyperten-
sion in this region [4]. Hypertension has been widely
studied in many community surveys in South Asia,
though nationally representative estimates are available
only in a few countries [5]. It is estimated that in the
year 2000, India had 41.5 million people with hyperten-
sion and the burden is projected to increase by another
5 million by the year 2025 [4]. The prevalence of hyper-
tension in adults was estimated to be 23 % and 18 % in
urban and rural areas respectively in the national health
survey of Pakistan, conducted during 1990–94 [5]. One
in four Sri Lankans over the age of 20 years was found
to have hypertension, with a prevalence of 27.8 % in
rural areas and 30.7 % in urban areas of the country, the
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latter being comparable with the prevalence of hyperten-
sion in developed countries [6,7].
Family history is an important non-modifiable risk fac-
tor for hypertension. The hereditary nature of hyperten-
sion is well established by numerous family studies [8],
demonstrating associations of blood pressure among sib-
lings and between parents and children [9]. About 30 %
of the blood pressure variance can be attributed to gen-
etic factors [10], and was found to vary from 25 % in
pedigree studies to 65 % in twin studies [9]. Among
various mechanisms proposed to explain the relation
between hypertension and positive family history of
hypertension, are the increased renal proximal sodium
reabsorption [11], genetic traits related to high blood
pressure such as high sodium-lithium counter-
transport, low urinary kallikrein excretion, elevated uric
acid level, high fasting plasma insulin concentrations,
high-density LDL sub-fractions, fat pattern index, oxi-
dative stress and body mass index, as well as shared en-
vironmental factors such as sodium intake and heavy
metal exposure [12-15].
Several associations were found between family history
and hypertension prevalence. In a nationwide screening
program, positive family history was found to be associ-
ated with hypertension prevalence double the value of
that found in persons with negative family history and
was independent of weight [16]. The evidence empha-
sizes the need to explore the family history of hyperten-
sion even in a normotensive individual. There is strong
evidence of early cardiac morphologic changes (greater
left ventricular wall thickness and mass) and altered per-
ipheral vascular capacity and responsivity to pressor
stimuli among normotensive individuals with a positive
family history [17]. Teenagers with hypertensive first-
degree relatives constitute a special risk group that
should be closely monitored [18]. Hypertension was
more likely to have been previously diagnosed in screen-
ing programmes if family history was positive [16].
Studying family history of hypertension and other risk
factors in healthy individuals provides a unique oppor-
tunity to explore factors leading to elevated blood pres-
sure, long before a diagnosis of hypertension is made
[19]. Positive family history therefore can be considered
as an opportunity for involving direct family members in
health education, as well as for early interventions and
improved control of hypertension [20].
To our knowledge presently there are no detailed ana-
lysis of the association between family history of hyper-
tension and the prevalence of the disease in a large
cohort of ethnic South Asian adults. The present study
aims to describe the influence of family history on
hypertension prevalence and associated metabolic risk
factors in a large cohort of South Asian adults, from a
nationally representative sample from Sri Lanka.
Methods
Study population and sampling
The present study was a cross-sectional community
based national survey conducted between August 2005
and September 2006 in seven of the nine provinces in
Sri Lanka. Detailed sampling has been described else-
where [21]. In brief, 5,000 adults (>18 years) were invited
for the study. A multi-stage stratified cluster sampling
technique used for recruitment. A total of 100 clusters
of 50 adults each were divided amongst the seven prov-
inces using a probability proportional to size (PPS) tech-
nique based on total provincial populations. In each
province the required number of clusters were selected
from a list of all ‘Village Officers Units’ in that province
by using a computer-generated random number list. The
voter registration lists of the selected ‘Village Officers
Units’ were used to randomly select the first household
in each cluster and a uniform criterion was used to se-
lect the remaining households. Ethical approval for the
study was obtained from the Ethics Review Committee,
Faculty of Medicine, University of Colombo, Sri Lanka.
Data collection
An interviewer administered questionnaire was used to
collect data, which included; age, gender, area of resi-
dence, ethnicity, level of education, household monthly
income (LKR-Sri Lankan Rupees), presence of hyperten-
sion and diabetes, family history of hypertension, height,
weight, waist circumference and hip circumference. Each
study participant was asked by direct questioning
whether any of his/her family members (living or not)
had hypertension, diagnosed by a physician. The family
history was evaluated at three levels, a) parents, b)
grandparents and c) siblings. The options provided were
‘yes’, ‘no’, and ‘don’t know’. For the purpose of analysis
those who said that they were unaware (‘don’t know’)
about the family history were excluded. In addition fam-
ily history was grouped into the following generations;
1st generation-siblings, 2nd generation-parents and 3rd
generation-grandparents. We also looked for the pres-
ence of hypertension amongst the children of the study
participants.
Data on self-reported physical activity were collected
using the short version of the International Physical Ac-
tivity Questionnaire (IPAQ). Height was measured using
Harpenden stadiometers (Chasmors Ltd, London, UK)
to the nearest 0.1 cm. Body weight was measured using
a SALTER 920 digital weighing scale (SALTER Ltd,
Tonbridge, UK) to the nearest 0.1 kg. Body Mass Index
(BMI) was calculated as weight in kilograms divided by
height squared in meters (kg/m2). Waist circumference
(WC) was measured midway between the iliac crest
and the lower rib margin at the end of normal expir-
ation and hip circumference was measured at the
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widest level over the greater trochanters using a plastic
flexible tape to the nearest 0.1 cm. Waist to Hip Ratio
(WHR) and Waist to Height Ratio (WHtR) were calcu-
lated as waist circumference divided by hip circumfer-
ence and height respectively. Seated blood pressure was
measured after at least a 10-min rest with Omron IA2
digital blood pressure monitors (Omron Healthcare,
Singapore). Fasting venous blood samples were obtained
for glucose and lipid estimation from all participants, de-
tails of analysis have been previously described [21].
Definitions
Hypertension was defined as systolic blood pressure >
140 mmHg and/or diastolic blood pressure > 90 mmHg
and/or being on anti-hypertensive treatment [22]. Par-
ticipants were considered to have diabetes if they had
been previously diagnosed at a government hospital or
by a registered medical practitioner. New cases (‘un-
diagnosed diabetes’) were diagnosed according to the
American Diabetes Association (ADA) and World
Health Organization (WHO) criteria [23,24]. Central obes-
ity was classified as WC> 90 cm for males and >80 cm for
females (Asian cut-offs) [25]. Obesity was defined as a
BMI ≥ 23 kg/m2, based on criteria for Asians [25]. Meta-
bolic Syndrome was defined according to the International
Diabetes Federation (IDF) criteria [26]. Urban and rural
sectors were defined according to the classification of the
Sri Lankan government. Physical activity was classified in
to three categories (‘Inactive’, ‘Moderately active’ and
‘Highly active’) based on the total MET minutes/week de-
rived from the IPAQ short version [21].
Statistical analysis
Data were analysed using SPSS v20 (SPSS Inc., Chicago,
IL, USA) statistical software package. The significance of
the differences between proportions and means was
tested using z-test and Student’s t-test or ANOVA re-
spectively. A binary logistic regression analysis was per-
formed in all patients with ‘presence of hypertension’ as
the dichotomous dependent variable (0 = hypertension
absent; 1 = hypertension present) and using family history
in parents, grandparents, siblings and children as the bin-
ary independent variables (0 = No, 1 = Yes). The explana-
tory variables selected above were subsequently included
in a binary logistic regression model, a backward elimin-
ation procedure was used and a p-value of 0.10 was con-
sidered as the cut off for removal of variables. A similar
binary logistic regression analysis with above dependant
and independent variables was also performed separately
for both males and females. We present the results of the
logistic regression analysis as odds ratio controlling for
confounders (age, gender, body mass index, diabetes,
hyperlipidaemia and physical activity). In all statistical
analyses p < 0.05 was considered significant.
Results
Sample characteristics
Out of the 5000 invited individuals 4482 participated in
the study (89.6 % response rate). Mean age (±SD) was
46.1 ± 15.1 years and 39.5 % (n = 1772) were males.
Majority were residing in rural areas (n = 3530, 78.7 %)
and Sinhalese in ethnicity (n = 3877, 86.4 %). The crude
prevalence of hypertension was 26.5 % (n = 1189, 95 %
CI: 25.2 - 27.8), of which 579 (12.9 %) were patients with
previously diagnosed hypertension. Urban adults (26.5 %)
had a significantly higher prevalence of hypertension than
their rural counterparts (22.9 %) (p < 0.05). Prevalence of
diabetes was 12.0 % (n = 536, 95 % CI: 11.0-12.9), and
26.6 % (n = 1193, 95 % CI: 25.3-27.9) had metabolic
syndrome.
Family history and prevalence of hypertension and
metabolic risk factors
The overall prevalence of family history in the popula-
tion was 43.5 % (n = 1951, 95 % CI: 42.0-45.0), irrespect-
ive of disease status. A family history of hypertension
(parents, grandparents or siblings) was present in
48.0 % (n = 1188, 95 % CI: 45.0-51.0) of patients with
hypertension and 41.9 % (n = 3293, 95 % CI: 40.0-44.0)
of participants without hypertension. In all adults the
prevalence of hypertension was significantly higher in
patients with a family history (29.3 %, 95 % CI: 27.3-
.31.3), than those without a family history (24.4 %, 95 %
CI: 22.7-26.0) (p < 0.001). A similar result was observed
in females (52.2 % Vs 47.8 %), but not for male partici-
pants (41.7 % Vs 58.3 %). Presence of a family history
significantly increased the risk of hypertension (OR:
1.29; 95 % CI: 1.13-1.47).
The prevalence of hypertension was higher in those
with a family history of hypertension at all levels (par-
ents, grandparents, siblings and children) than those
without a family history (Table 1). Among the different
ethnicities, the presence of a family history was highest
in Muslims (63.4 %) followed by Burger (57.1 %) and
Sinhalese (43.2 %). The prevalence of hypertension in
those with a family history was significantly higher in
each generations than in those without a family history
(1st generation [siblings] 45.4 % Vs 22.9 %, 2nd gener-
ation [parents] 27.5 % Vs 24.0 %, p < 0.001), but not in
3rd generation [grandparents] (13.6 % Vs 22.6 %). In
addition the prevalence of hypertension also increased
with the number of affected generations (one −25.7 %,
two-38.4 %, three-52.6 %, p < 0.001).
In patients without hypertension Obesity (37.0 % vs.
25.2 %; p < 0.001), Central obesity (30.3 % vs. 21.2 %;
p < 0.001) and metabolic syndrome (14.4 % vs. 11.0 %;
p < 0.01) were more prevalent in those with a family
history of hypertension than in those without. In this
group presence of family history of hypertension
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increased the risk of obesity (OR: 1.36; 95 % CI 1.27-1.45),
central obesity (OR: 1.30; 95 % CI 1.22 - 1.40) and meta-
bolic syndrome (OR: 1.19; 95 % CI 1.08 - 1.30). Similarly
in patients with hypertension the prevalence of Obesity
(60.1 % vs. 39.5 %; p < 0.01), Central obesity (53.7 % vs.
36.4 %; p < 0.001) and metabolic syndrome (47.7 % vs.
32.3 %; p < 0.01) all were significantly higher in those with
a family history of hypertension than in those without. In
patients with hypertension presence of family history of
hypertension increased the risk of obesity (OR: 1.54; 95 %
CI 1.39 - 1.71), central obesity (OR: 1.43; 95 % CI 1.27-
1.61) and metabolic syndrome (OR: 1.38; 95 % CI 1.26-
1.53).
Association of age, clinical and biochemical parameters
with family history
Table 2 summarizes the association between age, clinical
and biochemical parameters with family history in pa-
tients with and without diabetes. In both patients with
hypertension and without hypertension, those with a
family history were significantly younger and had a
higher mean BMI, waist circumference, hip circumfer-
ence and diastolic blood pressure. However, in the sub-
jects without hypertension, in addition to the above
mentioned parameter those with a family history also
had higher LDL cholesterol and triglycerides (Table 2).
In patients with hypertension the BMI, waist, hip cir-
cumferences and diastolic blood pressure significantly
increased when the number of generations affected by
hypertension increased from 1 to 2 (Table 3). A similar
trend was also observed amongst the subjects without
hypertension.
Given the strong influences of age and BMI on the
prevalence of hypertension, we tested separately the in-
fluence of family history on the prevalence of hyperten-
sion across commonly used age and BMI categories
(Fig. 1). In virtually every stratum of age (Fig. 1a) and
BMI (Fig. 1b), there was a clear stratification of risk for
Table 1 Presence of family history in different generations in patients with and without hypertension
Patients with hypertension (n = 1188) p* Patients without hypertension (n = 3293) p**
Family history (prevalence of hypertension) Family history (% without hypertension)
Present Absent Not known Present Absent Not known
Parents 416 (35.0) 676 (56.9) 96 (8.1) <0.001 1097 (33.3) 2139 (65.0) 57 (1.7) <0.001
Grandparents 32 (2.7) 675 (56.8) 481 (40.5) <0.001 204 (6.2) 2308 (70.1) 781 (23.7) <0.001
Siblings 264 (22.2) 851 (71.6) 50 (4.2) <0.001 318 (9.7) 2861 (86.9) 44 (1.3) <0.001
Children 54 (4.5) 996 (83.8) 13 (1.1) <0.001 22 (0.7) 2669 (81.1) 14 (0.4) <0.001
*Comparison between prevalence of hypertension in those with and without a family history; **Comparison between the percentage without hypertension in
those with and without a family history
Table 2 Association of age, clinical and biochemical parameters with family history
Patients with hypertension (n = 1188) p value* Patients without hypertension (n = 3293) p value*
Family history Family history
Present Absent Present Absent
(n = 572) (n = 616) (n = 1379) (n = 1914)
Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD)
Age (years) 52.9 (±12.6) 59.1 (±13.4) <0.001 40.4 (±12.3) 44.0 (±14.9) <0.001
Body Mass Index (kg/m2) 24.1 (±4.4) 22.1 (±4.3) <0.001 21.9 (±4.1) 20.8 (±3.9) <0.001
Waist circumference (cm) 84.3 (±11.6) 79.4 (±11.6) <0.001 77.6 (±11.5) 74.3 (±10.9) <0.001
Hip circumference (cm) 93.4 (±9.5) 88.9 (±9.2) <0.001 89.9 (±8.7) 86.9 (±8.6) <0.001
Waist to hip ratio 0.90 (±0.07) 0.89 (±0.07) 0.138 0.86 (±0.07) 0.85 (±0.07) <0.001
Systolic blood pressure (mmHg) 148.8 (±18.9) 151.1 (±19.8) 0.06 119.8 (±11.4) 118.2 (±11.8) 0.180
Diastolic blood pressure (mmHg) 86.8 (±11.0) 85.3 (±11.3) <0.05 72.5 (±8.1) 70.7 (±8.5) <0.05
Fasting blood glucose (mg/dl) 133.1 (±67.7) 123.3 (±58.1) <0.05 89.0 (±26.1) 88.4 (±26.5) 0.678
Total cholesterol (mg/dl) 221.1 (±43.1) 218.7 (±44.3) 0.355 204.4 (±41.0) 200.2 (±43.4) 0.108
LDL cholesterol (mg/dl) 145.3 (±38.5) 143.8 (±37.8) 0.516 134.2 (±35.1) 130.7 (±37.9) <0.05
HDL cholesterol (mg/dl) 46.5 (±9.6) 47.0 (±10.3) 0.399 46.8 (±10.8) 46.8 (±10.8) 0.644
Triglycerides (mg/dl) 146.7 (±76.4) 138.9 (±69.5) 0.07 116.5 (±63.4) 112.4 (±62.2) <0.05
*Patients with and without family history
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diabetes according to family history. In patients with
hypertension, those with a family history had a lower
total weekly MET minutes (3455) than those without a
family history (3773) (p-0.130). A similar result was ob-
served in the subjects without hypertension (4693 vs.
5387, p < 0.001). Patients with hypertension with a family
history were more ‘inactive’ (18.4 % vs. 14.8 %, p-0.135)
when self reported physical activity was classified in to the
three categories based on the total MET minutes/week.
This was not observed in non-hypertensive patients.
Logistic regression analysis
The overall model was statistically significant and the
Cox & Snell R-Square and Nagelkerke R Square values
were 0 .041 and 0.06 respectively. The results indicate
that in all adults presence of family history in parents
(OR: 1.28), siblings (OR: 1.27) and grandparents (OR:
1.34) all were associated with significantly increased risk
of developing hypertension (Table 4). Family history in
grandparents and siblings were also associated with de-
veloping hypertension in both males and females inde-
pendently (Table 4). However family history in parents
was not associated with an increase in risk of hyperten-
sion in males.
Discussion
To our knowledge this is the first comprehensive na-
tional survey evaluating the association between family
history of hypertension, disease prevalence and meta-
bolic risk factors from a nationally representative, large
cohort of ethnic South Asian adults from Sri Lanka. In
the present cohort those with a family history of
hypertension are nearly 1.4 times more likely to develop
hypertension than those without a family history. Previ-
ous studies from different countries have shown similar
increased risks [10,16,27,28], where compared to people
without a family history of hypertension, those who have
a family history were 2–4 times more likely to develop
hypertension [10,16]. However, the observed risks were
much higher in industrialised populations than reported
in the present cohort [10,27]. Furthermore our results
clearly demonstrate that family history of hypertension
has a graded association with hypertension, as the preva-
lence of hypertension increased with the number of gen-
erations with a family history.
The risk associated with family history in the current
population appeared to be independent of other known
risk factors, including age, anthropometric parameters
(BMI) and lifestyle factors (physical activity). The Johns
Hopkins Precursors Study has identified that hyperten-
sion in both mother and father has a strong independent
association with elevated BP levels and incident hyper-
tension over the course of adult life [29]. A nationwide
study involving over half a million study population has
described the association between family history and
hypertension is independent of weight [16]. Further-
more, family history and hypertension showed a graded
association, as the prevalence increased with the increas-
ing number of generations affected. A similar study has
shown that the strength of the association was related to
the type and number of relatives involved [30].
Participants with a family history of hypertension dis-
played a significantly higher mean BMI, waist and hip
circumference and diastolic blood pressure than those
Table 3 Association of age, clinical and biochemical parameters with number of generations with family history
Patients with hypertension & a family history of
hypertension (n = 508)
Patients without hypertension, with a family history of
hypertension (n = 1325)
One Generation
(n = 353)
Two Generations
(n = 145)
Three Generations
(n = 10)
One Generation
(n = 1085)
Two Generations
(n = 282)
Three Generations
(n = 9)
Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD)
Age (years) 51.8 (±12.7) 50.5 (±9.3) 45.8 (±10.3) 40.0 (±12.0) 39.2 (±11.3) 44.8 (±12.5)
Body Mass Index (kg/m2) 23.8 (±4.3)# 25.6 (±4.3)# 24.3 (±2.7) 21.8 (±4.0)¥δ 22.6 (±4.2)¥ 24.9 (±6.9)δ
Waist circumference (cm) 84.2 (±10.8)# 88.0 (±11.8)# 84.2 (±7.7) 77.1 (±11.4)¥δ 79.2 (±10.9)¥ 86.0 (±20.5)δ
Hip circumference (cm) 92.7 (±9.1)# 96.1 (±9.8)# 93.6 (±5.4) 89.5 (±8.5)¥ 91.6 (±9.2)¥ 94.5 (±14.2)
Waist to hip ratio 0.91 (±0.07) 0.93 (±0.07) 0.93 (±0.08) 0.86 (±0.07) 0.86 (±0.07) 0.90 (±0.07)
Systolic blood pressure (mmHg) 147.6 (±16.9)# 150.2 (±20.5)* 134.5 (±10.5)#* 119.6 (±11.4) 120.6 (±11.1) 125.1 (±10.6)
Diastolic blood pressure (mmHg) 86.5 (±10.6)# 89.6 (±11.0)# 84.1 (±7.9) 72.4 (±8.2) 73.0 (±8.0) 76.1 (±5.8)
Fasting blood glucose (mg/dl) 99.2 (±34.5) 105.7 (±38.5) 75.3 (±13.6) 88.4 (±23.3) 91.4 (±36.9) 82.5 (±12.9)
Total cholesterol (mg/dl) 220.5 (±43.3) 224.9 (±41.9) 204.1 (±41.8) 204.0 (±41.1) 206.0 (±40.7) 206.2 (±35.4)
LDL cholesterol (mg/dl) 144.6 (±39.4) 148.4 (±36.0) 136.8 (±41.0) 134.1 (±35.1) 134.9 (±35.7) 131.3 (±24.3)
HDL cholesterol (mg/dl) 46.2 (±9.7)# 46.8 (±9.7)* 39.5 (±5.5)#* 46.6 (±10.7) 47.7 (±11.0) 52.1 (±14.5)
Triglycerides (mg/dl) 148.0 (±84.7) 148.4 (±63.5) 138.5 (±59.7) 115.9 (±61.6) 115.8 (±68.1) 114.1 (±68.6)
*#¥δMean values in the same row with the same superscript are significantly different from each other (p < 0.05)
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without a family history, irrespective of hypertension sta-
tus, a finding which is in keeping with other similar
studies [20,31]. Furthermore, the anthropometric param-
eters in the present cohort showed a graded increase
with the increasing number of generations affected by
hypertension. Family history of hypertension was also
associated with the prevalence of obesity, central obesity
and metabolic syndrome. A study carried out in Japan
has identified that a maternal family history of hyperten-
sion was positively associated with the risk of overweight
in children and the risk increased with increasing num-
ber of affected family members [32]. A similar result was
observed in the present cohort, where in patients with
and without hypertension the BMI, waist and hip
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Fig. 1 Prevalence of hypertension by, a) age category and b) BMI in patients with and without a family history of hypertension
Table 4 Binary logistic regression analysis in all adults, males and females
Co-variants (Family history) Adjusted Odds Ratio (95 % CI)α
All adults (n = 4482) Males (n = 1772) Females (n = 2710)
Parents 1.28 (1.12 – 1.48)* 1.20 (0.90 – 1.51) 1.31 (1.11 – 1.51)*
Grandparents 1.34 (1.20 – 1.50)* 1.31 (1.21 – 1.53)* 1.17 (1.06 – 1.29)*
Siblings 1.27 (1.21 – 1.33)* 1.31 (1.11 – 1.56)* 1.24 (1.15 – 1.47)*
Children 0.90 (0.80 – 0.98) 0.89 (0.85 – 0.94) 0.91 (0.86 – 0.96)
*p <0.001; α – adjusted odds ratio controlling for confounders (age, gender, body mass index, diabetes, hyperlipidemia and physical activity)
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circumferences and diastolic blood pressure, significantly
increased with the increasing number of generations af-
fected by hypertension. Therefore it is considered that
for persons with positive family history, nutritional-
hygienic recommendations to avoid overweight may be
important in reducing the risk of becoming hypertensive
[16]. Further, early hemodynamic, neuro-humoral, and
metabolic alterations that are typical of hypertensive
metabolic syndrome have been demonstrated in off-
spring with malignant hypertensive parents [33]. Previ-
ous studies have also demonstrated an association
between the family history of hypertension and the pres-
ence of metabolic disorders and the clustering of these
disorders in offspring of the affected patients [34]. Also
in the present cohort, in the subjects without hyperten-
sion, in addition to mean BMI, waist and hip circumfer-
ence and diastolic blood pressure, those with a family
history also had higher LDL cholesterol and triglycer-
ides. Studies have demonstrated that a positive family
history of hypertension is associated with an initial in-
crease in markers of inflammation and plaque instability
in otherwise healthy young normotensive individuals,
likely conveying a predisposition to develop early athero-
thrombosis [35] and the relative risk for developing cor-
onary artery disease or cardiovascular death is increased
in patients with a family history of hypertension [10].
Hence the family history could be used as a tool to de-
tect not only those at risk of hypertension, but also a
constellation of other cardiovascular risk factors, and
they might form a group of individuals that will benefit
the most from targeted risk factor interventions.
We also observed that irrespective of the disease status
participants with a family history had a lower total
weekly MET minutes and were more ‘inactive’ in self re-
ported physical activity than those without a family his-
tory. Objectively measured physical activity is known to
have a significant correlation with blood pressure in
population-based samples from Nigeria, Jamaica and the
US [36]. These findings further support the hypothesis
that expression of complex traits like hypertension re-
sults from an interaction between shared genes, environ-
ments and behaviours [13,31]. Furthermore individuals
with a family history of hypertension form an easily
identifiable group who may benefit from targeted inter-
vention to prevent the development of hypertension
through increased physical activity. Patients with a fam-
ily history were younger in age than patients without a
family history of hypertension, a finding which is con-
sistent with previous studies among adults [20] and were
found to have an onset well before adolescence [37].
Family history is a common non-modifiable risk factor
for most chronic non-communicable diseases, as it is a
collective reflection of the genetic susceptibility, shared
environments and behaviours [31]. Hence, identifying
the family history will serve as a practical and useful ap-
proach [31] for public health and preventive medicine
[31,38]. The advantages of family history as a risk assess-
ment tool is the low cost, greater acceptability, and that
it is a reflection of the shared genetic and lifestyle fac-
tors. Although family history by itself is a non-
modifiable risk factor, it is useful for screening purposes
[16] to identify high risk population long before a diag-
nosis of hypertension is made [19], and to target inter-
ventions and disease prevention [31]. Awareness of risk
is a factor that promotes better and earlier health-related
behaviour [39] and lifestyle modifications are of proven
efficacy in primary prevention of hypertension [40].
Hence, overall there is promising potential for the use of
family history as a public health tool aiding prevention
of hypertension.
The strengths of the present study includes the large
and nationally representative nature of the sample, ran-
dom selection of participants out of a well-defined and
homogenous target population, the high response rate
and the detailed nature of clinical and demographic as-
sessment using well-validated tools. The major limitation
of the study was the cross-sectional nature. The useful-
ness of family history in risk prediction should be tested
in large prospective studies. Furthermore, in developing
countries like Sri Lanka, large sections of the community
remain undiagnosed and therefore the accuracy of self-
reported family history is a challenge. Family history was
evaluated using a simple questionnaire. Previous studies
have shown that compared with a detailed questionnaire,
the simple enquiry can correctly identify the majority of
individuals classified as having no significant family his-
tory; however it tends to miss a significant proportion of
individuals with a positive family history, a limitation
that applies to the present study as well [41]. Other po-
tential limitations include the recall bias for family his-
tory, however previous similar studies have shown
higher sensitivities for reporting family history of hyper-
tension [42]. In order to minimize recall bias we have
carried out a separate analysis on patients with newly di-
agnosed diabetes, which is presented as a supplementary
file (Additional file 1). The prevalence of diabetes in
newly diagnosed patients was significantly higher in
those with a family history in siblings or in children
(Additional file 1). However in the binary logistic ana-
lysis only a family history in siblings was shown to be
significantly associated with presence of hypertension
amongst newly diagnosed patients. Furthermore newly
diagnosed patients with a family history were younger in
age, and had a higher BMI, waist and hip circumference.
Conclusions
FH and hypertension had an association in the Sri
Lankan population, as the prevalence of hypertension
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was significantly higher in those with a FH of hyper-
tension. We also observed an increase in the preva-
lence with the increasing number of generations
affected. FH of hypertension was also associated with
the prevalence of obesity, central obesity and meta-
bolic syndrome. Individuals with a FH of hypertension
form an easily identifiable group who may benefit
from targeted interventions.
Additional file
Additional file 1: Table S1. Presence of family history in different
generations in newly diagnosed patients with hypertension. Table S2.
Association of age, clinical and biochemical parameters with family
history in patients with newly diagnosed hypertension. Table S3: Binary
logistic regression analysis in all adults, males and females.
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